156 related articles for article (PubMed ID: 16276037)
1. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model.
Takano N; Sakurai T; Kurachi M
J Pharmacol Sci; 2005 Nov; 99(3):277-86. PubMed ID: 16276037
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
3. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
[TBL] [Abstract][Full Text] [Related]
4. [Effects of ethanol extracts of herbal medicines on dermatitis in an atopic dermatitis mouse model].
Takano N; Inokuchi Y; Kurachi M
Yakugaku Zasshi; 2011 Apr; 131(4):581-6. PubMed ID: 21467798
[TBL] [Abstract][Full Text] [Related]
5. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice.
Tanaka A; Matsuda H
J Vet Med Sci; 2005 Sep; 67(9):915-9. PubMed ID: 16210804
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor (NGF) and epidermal nerve fibers in atopic dermatitis model NC/Nga mice.
Horiuchi Y; Bae S; Katayama I
J Dermatol Sci; 2005 Jul; 39(1):56-8. PubMed ID: 15893456
[No Abstract] [Full Text] [Related]
7. Transforming growth factor-beta1 suppresses atopic dermatitis-like skin lesions in NC/Nga mice.
Sumiyoshi K; Nakao A; Ushio H; Mitsuishi K; Okumura K; Tsuboi R; Ra C; Ogawa H
Clin Exp Allergy; 2002 Feb; 32(2):309-14. PubMed ID: 11929498
[TBL] [Abstract][Full Text] [Related]
8. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
Takano N; Arai I; Kurachi M
Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
[TBL] [Abstract][Full Text] [Related]
10. A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.
Ikezawa Z; Komori J; Ikezawa Y; Inoue Y; Kirino M; Katsuyama M; Aihara M
Allergy Asthma Immunol Res; 2010 Oct; 2(4):235-46. PubMed ID: 20885908
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis.
Grimstad O; Sawanobori Y; Vestergaard C; Bilsborough J; Olsen UB; Grønhøj-Larsen C; Matsushima K
Exp Dermatol; 2009 Jan; 18(1):35-43. PubMed ID: 19054054
[TBL] [Abstract][Full Text] [Related]
12. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis.
Tominaga M; Ozawa S; Ogawa H; Takamori K
J Dermatol Sci; 2007 Jun; 46(3):199-210. PubMed ID: 17350228
[TBL] [Abstract][Full Text] [Related]
13. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
14. Itch-associated scratching contributes to the development of dermatitis and hyperimmunoglobulinaemia E in NC/Nga mice.
Hashimoto Y; Takaoka A; Sugimoto M; Honma Y; Sakurai T; Futaki N; Arai I
Exp Dermatol; 2011 Oct; 20(10):820-5. PubMed ID: 21771100
[TBL] [Abstract][Full Text] [Related]
15. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
16. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model.
Tokime K; Katoh-Semba R; Yamanaka K; Mizoguchi A; Mizutani H
Arch Dermatol Res; 2008 Aug; 300(7):343-52. PubMed ID: 18443810
[TBL] [Abstract][Full Text] [Related]
17. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides concentrations in the skin of a murine (NC/Nga mice) model of atopic dermatitis.
Katsuno M; Aihara M; Kojima M; Osuna H; Hosoi J; Nakamura M; Toyoda M; Matsuda H; Ikezawa Z
J Dermatol Sci; 2003 Oct; 33(1):55-65. PubMed ID: 14527739
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
[TBL] [Abstract][Full Text] [Related]
20. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
